NovelBeamUSA is a brand name for NovelBeam Technology, which is dedicated to the development and manufacturing of cutting-edge life science instrumentation, emphasizing innovation, precision, and reliability. NovelBeamUSA are currently advancing point-of-care testing (POCT), fluorometer, and polymerase chain reaction (PCR) technologies to deliver high-performance solutions that empower scientific discovery and improve healthcare outcomes.
NovelBeam Technology is wholly owned by Qingdao NovelBeam Technology Co. Ltd, which is listed on the Shanghai Stock Exchange. Visit https://en.novelbeam.com/ to learn more.
